Private Advisor Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.41M | Buy |
2,506
+712
| +40% | +$457K | 0.01% | 1217 |
|
|
2025
Q4 | $1.21M | Sell |
1,794
-451
| -20% | -$307K | 0.01% | 1303 |
|
|
2025
Q3 | $1.43M | Sell |
2,245
-89
| -4% | -$54K | 0.01% | 1168 |
|
|
2025
Q2 | $1.25M | Buy |
2,334
+246
| +12% | +$118K | 0.01% | 1189 |
|
|
2025
Q1 | $877K | Buy |
2,088
+295
| +16% | +$128K | 0.01% | 1316 |
|
|
2024
Q4 | $741K | Sell |
1,793
-269
| -13% | -$118K | ﹤0.01% | 1373 |
|
|
2024
Q3 | $1.04M | Sell |
2,062
-225
| -10% | -$109K | 0.01% | 1211 |
|
|
2024
Q2 | $1.11M | Buy |
2,287
+183
| +9% | +$91.9K | 0.01% | 1137 |
|
|
2024
Q1 | $1.14M | Sell |
2,104
-85
| -4% | -$46.5K | 0.01% | 1108 |
|
|
2023
Q4 | $1.22M | Buy |
2,189
+261
| +14% | +$123K | 0.01% | 1019 |
|
|
2023
Q3 | $843K | Buy |
1,928
+126
| +7% | +$62.8K | 0.01% | 1126 |
|
|
2023
Q2 | $938K | Buy |
1,802
+274
| +18% | +$131K | 0.01% | 1079 |
|
|
2023
Q1 | $764K | Sell |
1,528
-44
| -3% | -$21.1K | 0.01% | 1126 |
|
|
2022
Q4 | $302K | Buy |
1,572
+254
| +19% | +$98.6K | 0.02% | 748 |
|
|
2022
Q3 | $429K | Sell |
1,318
-4,298
| -77% | -$1.58M | ﹤0.01% | 1315 |
|
|
2022
Q2 | $1.97M | Buy |
5,616
+208
| +4% | +$84.8K | 0.02% | 767 |
|
|
2022
Q1 | $2.96M | Sell |
5,408
-3,101
| -36% | -$1.63M | 0.02% | 635 |
|
|
2021
Q4 | $5.6M | Sell |
8,509
-3,185
| -27% | -$2M | 0.04% | 416 |
|
|
2021
Q3 | $7.27M | Buy |
11,694
+2,951
| +34% | +$1.98M | 0.05% | 397 |
|
|
2021
Q2 | $5.52M | Sell |
8,743
-342
| -4% | -$189K | 0.05% | 377 |
|
|
2021
Q1 | $4.45M | Buy |
9,085
+131
| +1% | +$65.6K | 0.04% | 418 |
|
|
2020
Q4 | $4.48M | Buy |
8,954
+675
| +8% | +$302K | 0.05% | 362 |
|
|
2020
Q3 | $3.12M | Buy |
8,279
+66
| +0.8% | +$24.4K | 0.04% | 406 |
|
|
2020
Q2 | $2.71M | Buy |
8,213
+3,274
| +66% | +$948K | 0.04% | 427 |
|
|
2020
Q1 | $1.2M | Sell |
4,939
-2,756
| -36% | -$719K | 0.02% | 597 |
|
|
2019
Q4 | $2.01M | Buy |
7,695
+2,867
| +59% | +$755K | 0.03% | 529 |
|
|
2019
Q3 | $1.31M | Buy |
4,828
+577
| +14% | +$161K | 0.02% | 683 |
|
|
2019
Q2 | $1.08M | Buy |
4,251
+95
| +2% | +$23.4K | 0.02% | 708 |
|
|
2019
Q1 | $851K | Buy |
4,156
+1,459
| +54% | +$301K | 0.02% | 744 |
|
|
2018
Q4 | $501K | Sell |
2,697
-1,465
| -35% | -$300K | 0.01% | 839 |
|
|
2018
Q3 | $1.04M | Buy |
4,162
+2,416
| +138% | +$586K | 0.02% | 666 |
|
|
2018
Q2 | $386K | Buy |
+1,746
| New | +$360K | 0.01% | 869 |
|
|
2018
Q1 | – | Sell |
-1,334
| Closed | -$218K | – | 1255 |
|
|
2017
Q4 | $218K | Sell |
1,334
-75
| -5% | -$11.8K | 0.01% | 1037 |
|
|
2017
Q3 | $222K | Sell |
1,409
-45
| -3% | -$7.12K | 0.01% | 1298 |
|
|
2017
Q2 | $235K | Sell |
1,454
-232
| -14% | -$37.7K | 0.01% | 1193 |
|
|
2017
Q1 | $261K | Buy |
+1,686
| New | +$232K | 0.01% | 1146 |
|
Other funds holding IDXX
VCM
VPM
Private Advisor Group's IDXX Position: Q1 2026 in Review
Private Advisor Group increased its Idexx Laboratories (IDXX) stake by 40% in Q1 2026, buying an estimated $457K and bringing the position to 2,506 shares worth $1.41M. The position accounts for 0.01% of the portfolio, ranked #1217.
Private Advisor Group first reported a position in IDXX in Q1 2017 and has held it in 36 quarters since. The position peaked at $7.27M in Q3 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Private Advisor Group held 2,506 shares of Idexx Laboratories worth $1.41M as of Q1 2026.
- Private Advisor Group bought 712 Idexx Laboratories shares in Q1 2026, an estimated $457K.
- Idexx Laboratories made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #1217 holding.
- Private Advisor Group first reported a position in Idexx Laboratories in Q1 2017 and has held it in 36 quarters since.
- Private Advisor Group's Idexx Laboratories position peaked at $7.27M in Q3 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.